Myriad Genetics Inc
AED14.45
AED
Last updated on --.
24h volume866.01K
24h highest14.5072 AED
24h lowest14.0481 AED
24h Price movement+2.21%
MYGN recent prices
24 Hours
+2.21%+AED0.31218
30 days
-20.14%-AED3.581
60 days
-11.35%-AED1.818
90 days
-16.16%-AED2.737
Key data
Previous close14.1399 AED
Market cap1.32B AED
Volume866.01K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-15.5355 AED
Net income (FY)-1.47B AED
Revenue (FY)3.04B AED
Last report dateMay 6, 2026
About Myriad Genetics Inc
HeadquartersSALT LAKE CITY
Employees (FY)2.70K
Revenue per employee (FY)1.13M AED
Net income per employee (FY)-543.97K AED
Listed onNasdaq
MYGN conversion tables
 |  |
|---|---|
| 0.5 MYGN | 7.226 AED |
| 1 MYGN | 14.45 AED |
| 5 MYGN | 72.26 AED |
| 10 MYGN | 144.52 AED |
| |
|---|---|
| 0.5 AED | 0.034597 MYGN |
| 1 AED | 0.069194 MYGN |
| 5 AED | 0.34597 MYGN |
| 10 AED | 0.69194 MYGN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
MYGN is trading at AED14.45, +2.21% over the last 24 hours. Track live moves on the price chart at the top of this page.
The MYGN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. MYGN is currently trading at AED14.45, +2.21% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on MYGN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. MYGN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from MYGN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against MYGN's historical range and other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Myriad Genetics Inc's market cap is currently 1.32B AED. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume866.01K
24h highest14.5072 AED
24h lowest14.0481 AED
24h Price movement+2.21%
Start trade with MYGN Perpetual
Sign up to trade